Log in

XBiotech News Headlines (NASDAQ:XBIT)

$24.30
-0.59 (-2.37 %)
(As of 01/17/2020 04:00 PM ET)
Today's Range
$23.78
Now: $24.30
$25.00
50-Day Range
$10.88
MA: $18.03
$24.90
52-Week Range
$5.41
Now: $24.30
$26.40
Volume1.31 million shs
Average Volume1.23 million shs
Market Capitalization$998.41 million
P/E RatioN/A
Dividend YieldN/A
Beta0.64

Headlines

XBiotech (NASDAQ XBIT) News Headlines

Source:
DateHeadline
XBiotech Target of Unusually High Options Trading (NASDAQ:XBIT)XBiotech Target of Unusually High Options Trading (NASDAQ:XBIT)
www.americanbankingnews.com - January 16 at 6:03 PM
XBiotech Is Trading Below Its $30 Offer Price For Good Reason, But It Still Could Rise - Seeking AlphaXBiotech Is Trading Below Its $30 Offer Price For Good Reason, But It Still Could Rise - Seeking Alpha
seekingalpha.com - January 16 at 12:46 PM
XBiotech (XBIT) Commences Tender Offer to Purchase up to $420M of its Shares at $30 to $33 Per Share - StreetInsider.comXBiotech (XBIT) Commences Tender Offer to Purchase up to $420M of its Shares at $30 to $33 Per Share - StreetInsider.com
www.streetinsider.com - January 16 at 12:09 AM
Better Buy: Shopify vs. Square - NasdaqBetter Buy: Shopify vs. Square - Nasdaq
www.nasdaq.com - January 15 at 9:08 AM
How Does Your Retirement Savings Rate Compare With the Average? - NasdaqHow Does Your Retirement Savings Rate Compare With the Average? - Nasdaq
www.nasdaq.com - January 14 at 8:44 PM
Why Perrigo Shares Are Jumping Today - NasdaqWhy Perrigo Shares Are Jumping Today - Nasdaq
www.nasdaq.com - January 14 at 8:44 PM
Illumina and Roche Combine For Genomics Oncology Deal - NasdaqIllumina and Roche Combine For Genomics Oncology Deal - Nasdaq
www.nasdaq.com - January 14 at 8:44 PM
Why Pinterest Stock Popped 10.5% Today - NasdaqWhy Pinterest Stock Popped 10.5% Today - Nasdaq
www.nasdaq.com - January 14 at 8:44 PM
Vishay Precision To Present At Needham Growth Conference; Webcast At 4:10 PM ET - NasdaqVishay Precision To Present At Needham Growth Conference; Webcast At 4:10 PM ET - Nasdaq
www.nasdaq.com - January 14 at 8:44 PM
48 Stocks Moving In Tuesdays Mid-Day Session - Benzinga48 Stocks Moving In Tuesday's Mid-Day Session - Benzinga
www.benzinga.com - January 14 at 3:43 PM
Play These ETFs on Visa-Plaid Deal - NasdaqPlay These ETFs on Visa-Plaid Deal - Nasdaq
www.nasdaq.com - January 14 at 3:43 PM
Why LivePerson Stock Jumped 96.2% in 2019 - NasdaqWhy LivePerson Stock Jumped 96.2% in 2019 - Nasdaq
www.nasdaq.com - January 14 at 3:43 PM
Why XBiotech Shares Are Skyrocketing 32.7% Today - Motley FoolWhy XBiotech Shares Are Skyrocketing 32.7% Today - Motley Fool
www.fool.com - January 14 at 3:43 PM
Mid-Morning Market Update: Markets Mostly Lower; JPMorgan Tops Q4 Expectations - BenzingaMid-Morning Market Update: Markets Mostly Lower; JPMorgan Tops Q4 Expectations - Benzinga
www.benzinga.com - January 14 at 10:43 AM
BYND, FCEL among premarket gainers - Seeking AlphaBYND, FCEL among premarket gainers - Seeking Alpha
seekingalpha.com - January 14 at 10:43 AM
XBiotech +39% on tender offer to purchase $420M shares - Seeking AlphaXBiotech +39% on tender offer to purchase $420M shares - Seeking Alpha
seekingalpha.com - January 14 at 10:43 AM
Form SC TO-I XBiotech Inc. Filed by: XBiotech Inc. - StreetInsider.comForm SC TO-I XBiotech Inc. Filed by: XBiotech Inc. - StreetInsider.com
www.streetinsider.com - January 14 at 10:43 AM
XBiotech Commences Tender Offer to Purchase up to $420,000,000 of its SharesXBiotech Commences Tender Offer to Purchase up to $420,000,000 of its Shares
finance.yahoo.com - January 14 at 10:42 AM
XBiotech Inc (NASDAQ:XBIT) Sees Significant Growth in Short InterestXBiotech Inc (NASDAQ:XBIT) Sees Significant Growth in Short Interest
www.americanbankingnews.com - January 14 at 1:58 AM
Brokerages Anticipate XBiotech Inc (NASDAQ:XBIT) to Post ($0.15) Earnings Per ShareBrokerages Anticipate XBiotech Inc (NASDAQ:XBIT) to Post ($0.15) Earnings Per Share
www.americanbankingnews.com - January 13 at 2:34 PM
XBiotech Inc (NASDAQ:XBIT) Expected to Announce Earnings of -$0.15 Per ShareXBiotech Inc (NASDAQ:XBIT) Expected to Announce Earnings of -$0.15 Per Share
www.americanbankingnews.com - January 13 at 8:20 AM
Janssen completes $750M acquisition - Philadelphia Business JournalJanssen completes $750M acquisition - Philadelphia Business Journal
www.bizjournals.com - December 31 at 4:45 PM
Janssen Announces Completion of Acquisition of Investigational Bermekimab from XBiotech Inc.Janssen Announces Completion of Acquisition of Investigational Bermekimab from XBiotech Inc.
www.prnewswire.com - December 30 at 4:21 PM
XBiotech Closes on Sale of True Human Antibody Bermekimab to Janssen - GlobeNewswireXBiotech Closes on Sale of True Human Antibody Bermekimab to Janssen - GlobeNewswire
www.globenewswire.com - December 30 at 4:21 PM
XBiotech Closes on Sale of True Human Antibody Bermekimab to JanssenXBiotech Closes on Sale of True Human Antibody Bermekimab to Janssen
finance.yahoo.com - December 30 at 4:21 PM
Zacks: XBiotech Inc (NASDAQ:XBIT) Receives Consensus Rating of "Strong Buy" from BrokeragesZacks: XBiotech Inc (NASDAQ:XBIT) Receives Consensus Rating of "Strong Buy" from Brokerages
www.americanbankingnews.com - December 29 at 6:22 AM
XBiotech Inc (NASDAQ:XBIT) Short Interest Down 24.1% in DecemberXBiotech Inc (NASDAQ:XBIT) Short Interest Down 24.1% in December
www.americanbankingnews.com - December 27 at 5:22 AM
XBiotech Inc. (XBIT): Are Hedge Funds Right About This Stock? - Yahoo FinanceXBiotech Inc. (XBIT): Are Hedge Funds Right About This Stock? - Yahoo Finance
finance.yahoo.com - December 20 at 5:31 PM
XBiotech Inc. (XBIT): Are Hedge Funds Right About This Stock?XBiotech Inc. (XBIT): Are Hedge Funds Right About This Stock?
finance.yahoo.com - December 20 at 5:31 PM
XBiotech Added to NASDAQ Biotechnology Index - Yahoo FinanceXBiotech Added to NASDAQ Biotechnology Index - Yahoo Finance
finance.yahoo.com - December 17 at 10:38 AM
Mid-Afternoon Market Update: Dow Falls 90 Points; XBiotech Shares Spike Higher - BenzingaMid-Afternoon Market Update: Dow Falls 90 Points; XBiotech Shares Spike Higher - Benzinga
www.benzinga.com - December 9 at 11:54 PM
20 Stocks Moving In Mondays Pre-Market Session - Benzinga20 Stocks Moving In Monday's Pre-Market Session - Benzinga
www.benzinga.com - December 9 at 8:52 AM
XBiotech (XBIT) Reports Sale of True Human Antibody Bermekimab Targeting IL-1a to Janssen Pharma (JNJ) - StreetInsider.comXBiotech (XBIT) Reports Sale of True Human Antibody Bermekimab Targeting IL-1a to Janssen Pharma (JNJ) - StreetInsider.com
www.streetinsider.com - December 9 at 8:52 AM
Sensex, Nifty Seen Opening Lower - NasdaqSensex, Nifty Seen Opening Lower - Nasdaq
www.nasdaq.com - December 8 at 10:20 PM
Janssen To Buy Investigational Bermekimab From XBiotech - NasdaqJanssen To Buy Investigational Bermekimab From XBiotech - Nasdaq
www.nasdaq.com - December 8 at 10:20 PM
XBiotech Announces Agreement to Sell True Human Antibody Bermekimab Targeting IL-1a to Janssen - GlobeNewswireXBiotech Announces Agreement to Sell True Human Antibody Bermekimab Targeting IL-1a to Janssen - GlobeNewswire
www.globenewswire.com - December 7 at 1:32 PM
Noteworthy Monday Option Activity: GRUB, SPLK, XBITNoteworthy Monday Option Activity: GRUB, SPLK, XBIT
www.nasdaq.com - December 2 at 5:48 PM
XBiotech Announces Rapid Enrollment for its Randomized Multi-Center Clinical Study for Bermekimab in Patients with Hidradenitis Suppurativa - GlobeNewswireXBiotech Announces Rapid Enrollment for its Randomized Multi-Center Clinical Study for Bermekimab in Patients with Hidradenitis Suppurativa - GlobeNewswire
www.globenewswire.com - November 21 at 1:15 AM
Healthcare Stocks That Hit New Highs (XBIT, DRNA, CRSP...) - NasdaqHealthcare Stocks That Hit New Highs (XBIT, DRNA, CRSP...) - Nasdaq
www.nasdaq.com - November 19 at 1:31 PM
XBiotech (XBIT) Announces Rapid Enrollment for its Randomized Multi-Center Clinical Study for Bermekimab in Patients with HS - StreetInsider.comXBiotech (XBIT) Announces Rapid Enrollment for its Randomized Multi-Center Clinical Study for Bermekimab in Patients with HS - StreetInsider.com
www.streetinsider.com - November 19 at 1:31 PM
XBiotech Announces Rapid Enrollment for its Randomized Multi-Center Clinical Study for Bermekimab in Patients with Hidradenitis Suppurativa - StreetInsider.comXBiotech Announces Rapid Enrollment for its Randomized Multi-Center Clinical Study for Bermekimab in Patients with Hidradenitis Suppurativa - StreetInsider.com
www.streetinsider.com - November 19 at 1:31 PM
The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGenes Blood Cancer Drug Gets Approval - Yahoo FinanceThe Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval - Yahoo Finance
finance.yahoo.com - November 15 at 12:22 PM
XBiotech (XBIT) Reports First Patient Enrolled in Placebo-Controlled Clinical Study Evaluating Its anti-IL-1a Therapy Bermekimab - StreetInsider.comXBiotech (XBIT) Reports First Patient Enrolled in Placebo-Controlled Clinical Study Evaluating Its anti-IL-1a Therapy Bermekimab - StreetInsider.com
www.streetinsider.com - November 12 at 7:06 PM
XBiotech Announces First Patient Enrolled in...XBiotech Announces First Patient Enrolled in...
www.benzinga.com - November 12 at 9:04 AM
XBiotech Announces First Patient Enrolled in Placebo-Controlled Clinical Study Evaluating Its anti-IL-1⍺ Therapy Bermekimab in Patients with Atopic Dermatitis (Eczema)XBiotech Announces First Patient Enrolled in Placebo-Controlled Clinical Study Evaluating Its anti-IL-1⍺ Therapy Bermekimab in Patients with Atopic Dermatitis (Eczema)
finance.yahoo.com - November 12 at 9:04 AM
XBiotech IncXBiotech Inc
www.bloomberg.com - October 24 at 12:11 AM
XBiotech commences mid-stage study of bermekimab in painful skin disorderXBiotech commences mid-stage study of bermekimab in painful skin disorder
seekingalpha.com - October 24 at 12:11 AM
XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa - GlobeNewswireXBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa - GlobeNewswire
www.globenewswire.com - October 23 at 8:57 AM
XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis SuppurativaXBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa
finance.yahoo.com - October 23 at 8:57 AM
Cancer Cachexia Market to Reflect a Holistic Expansion During 2026 – Top Companies like Bristol-Myers Squibb Co., XBiotech Inc., Marsala Biotech Inc., Inovio Pharmaceuticals, Inc., Inc., Astellas Pharma Inc. and Others - Yahoo FinanceCancer Cachexia Market to Reflect a Holistic Expansion During 2026 – Top Companies like Bristol-Myers Squibb Co., XBiotech Inc., Marsala Biotech Inc., Inovio Pharmaceuticals, Inc., Inc., Astellas Pharma Inc. and Others - Yahoo Finance
finance.yahoo.com - October 11 at 10:46 AM
This page was last updated on 1/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel